{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:39:03Z","timestamp":1793111943824,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04474-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:54:51Z","timestamp":1783475691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and risk factors for mortality in pulmonary mucormycosis among patients with non-hematologic malignancies"],"prefix":"10.1186","volume":"26","author":[{"given":"Renwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"3","key":"4474_CR1","doi-asserted-by":"publisher","first-page":"e0092022","DOI":"10.1128\/mbio.00920-22","volume":"13","author":"S Bretagne","year":"2022","unstructured":"Bretagne S, Sitbon K, Desnos-Ollivier M, Garcia-Hermoso D, Letscher-Bru V, Cassaing S, Millon L, Morio F, Gangneux JP, Hasseine L, et al. Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF Network (2012 to 2018). mBio. 2022;13(3):e0092022. https:\/\/doi.org\/10.1128\/mbio.00920-22.","journal-title":"mBio"},{"issue":"1","key":"4474_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","volume":"25","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, Chen SC. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26\u201334. https:\/\/doi.org\/10.1016\/j.cmi.2018.07.011.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"4474_CR3","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","volume":"54","author":"G Petrikkos","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23\u201334. https:\/\/doi.org\/10.1093\/cid\/cir866.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"4474_CR4","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/cid\/cir865","volume":"54","author":"AS Ibrahim","year":"2012","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S16\u201322. https:\/\/doi.org\/10.1093\/cid\/cir865.","journal-title":"Clin Infect Dis"},{"key":"4474_CR5","doi-asserted-by":"publisher","unstructured":"Petrikkos G, Tsioutis C. Recent advances in the pathogenesis of mucormycoses. Clin Ther. 2018;40(6):894\u2013902.https:\/\/doi.org\/10.1016\/j.clinthera.2018.03.009.","DOI":"10.1016\/j.clinthera.2018.03.009"},{"issue":"Suppl 1","key":"4474_CR6","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1093\/cid\/cir880","volume":"54","author":"F Lanternier","year":"2012","unstructured":"Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O, French mycosis study group. A global analysis of mucormycosis in France: the RetroZygo Study (2005\u20132007). Clin Infect Dis. 2012;54(Suppl 1):S35\u201343. https:\/\/doi.org\/10.1093\/cid\/cir880.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4474_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3390\/jof9050592","volume":"9","author":"N Yang","year":"2023","unstructured":"Yang N, Zhang L, Feng S. Clinical features and treatment progress of invasive mucormycosis in patients with hematological malignancies. J Fungi (Basel). 2023;9(5):592. https:\/\/doi.org\/10.3390\/jof9050592.","journal-title":"J Fungi (Basel)"},{"issue":"12","key":"4474_CR8","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the european confederation of medical mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis. 2019;19(12):e405\u201321. https:\/\/doi.org\/10.1016\/S1473-3099(19)30312-3.","journal-title":"Lancet Infect Dis"},{"issue":"suppl1","key":"4474_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/mmy\/myx101","volume":"56","author":"A Skiada","year":"2018","unstructured":"Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56(suppl1):93\u2013101. https:\/\/doi.org\/10.1093\/mmy\/myx101.","journal-title":"Med Mycol"},{"issue":"3","key":"4474_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/jof9030307","volume":"9","author":"F Danion","year":"2023","unstructured":"Danion F, Coste A, Le Hyaric C, Melenotte C, Lamoth F, Calandra T, Garcia-Hermoso D, Aimanianda V, Lanternier F, Lortholary O. What is new in pulmonary mucormycosis? J Fungi (Basel). 2023;9(3):307. https:\/\/doi.org\/10.3390\/jof9030307.","journal-title":"J Fungi (Basel)"},{"issue":"12","key":"4474_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/jof11120853","volume":"11","author":"J Bo\u00e1n","year":"2025","unstructured":"Bo\u00e1n J, Fern\u00e1ndez-Ruiz M, Aparicio-Minguij\u00f3n E, Aguado JM. The unnoticed threat: clinical characteristics, risk factors, and outcome of mucormycosis in solid organ transplantation. J Fungi (Basel). 2025;11(12):853. https:\/\/doi.org\/10.3390\/jof11120853.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"4474_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s12890-025-04017-w","volume":"25","author":"N Duong-Minh","year":"2025","unstructured":"Duong-Minh N, Nguyen-Dang K. Pulmonary mucormycosis complicated by necrotizing pneumonia secondary to an obstructive endobronchial tumor-like lesion: a case report and review of literature. BMC Pulm Med. 2025;25(1):530. https:\/\/doi.org\/10.1186\/s12890-025-04017-w.","journal-title":"BMC Pulm Med"},{"issue":"5","key":"4474_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.chest.2023.06.039","volume":"164","author":"A Coste","year":"2023","unstructured":"Coste A, Conrad A, Porcher R, Poir\u00e9e S, Peterlin P, Defrance C, Letscher-Bru V, Morio F, Gastinne T, Bougnoux ME, et al. Improving diagnosis of pulmonary mucormycosis: leads from a contemporary national study of 114 cases. Chest. 2023;164(5):1097\u2013107. https:\/\/doi.org\/10.1016\/j.chest.2023.06.039.","journal-title":"Chest"},{"issue":"6","key":"4474_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, the mycoses study group education and research consortium. revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and. Clin Infect Dis. 2020;71(6):1367\u201376. https:\/\/doi.org\/10.1093\/cid\/ciz1008.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4474_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4329\/wjr.v12.i4.29","volume":"12","author":"K Ansari-Gilani","year":"2020","unstructured":"Ansari-Gilani K, Chalian H, Rassouli N, Bedayat A, Kalisz K. Chronic airspace disease: Review of the causes and key computed tomography findings. World J Radiol. 2020;12(4):29\u201347. https:\/\/doi.org\/10.4329\/wjr.v12.i4.29.","journal-title":"World J Radiol"},{"issue":"9","key":"4474_CR16","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/S1473-3099(22)00124-4","volume":"22","author":"V Muthu","year":"2022","unstructured":"Muthu V, Agarwal R, Patel A, Kathirvel S, Abraham OC, Aggarwal AN, Bal A, Bhalla AS, Chhajed PN, Chaudhry D, et al. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the fungal infection study forum and academy of pulmonary sciences, India. Lancet Infect Dis. 2022;22(9):e240\u201353. https:\/\/doi.org\/10.1016\/S1473-3099(22)00124-4.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"4474_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/590004","volume":"47","author":"G Chamilos","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503\u20139. https:\/\/doi.org\/10.1086\/590004.","journal-title":"Clin Infect Dis"},{"key":"4474_CR18","doi-asserted-by":"publisher","unstructured":"Gobeil SM, Bobay BG, Juvvadi PR, Cole DC, Heitman J, Steinbach WJ, Venters RA, Spicer LD. mBio. 2021;12(6):e0300021. Leveraging fungal and human calcineurin-inhibitor structures, biophysical data, and dynamics to design selective and nonimmunosuppressive FK506 Analogs. https:\/\/doi.org\/10.1128\/mBio.03000-21.\u00a0","DOI":"10.1128\/mBio.03000-21"},{"issue":"2","key":"4474_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3760\/cma.j.cn112147-20220530-00468","volume":"46","author":"M Tengfei","year":"2023","unstructured":"Tengfei M, Ruiying W, Min X. Pathogenesis of pulmonary mucormycosis in diabetic patients. Chin J Tuberculosis Respiratory. 2023;46(2):202\u20135. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20220530-00468.","journal-title":"Chin J Tuberculosis Respiratory"},{"key":"4474_CR20","doi-asserted-by":"publisher","first-page":"770551","DOI":"10.3389\/fcimb.2021.770551","volume":"11","author":"J Qu","year":"2021","unstructured":"Qu J, Liu X, Lv X. Pulmonary mucormycosis as the leading clinical type of mucormycosis in Western China. Front Cell Infect Microbiol. 2021;11:770551. https:\/\/doi.org\/10.3389\/fcimb.2021.770551.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4474_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13045-019-0785-7","volume":"12","author":"W Liu","year":"2019","unstructured":"Liu W, Liu J, Song Y, Zeng X, Wang X, Mi L, Cai C, Wang L, Ma J, Zhu J, et al. Burden of lymphoma in China, 2006\u20132016: an analysis of the global burden of disease study 2016. J Hematol Oncol. 2019;12(1):115. https:\/\/doi.org\/10.1186\/s13045-019-0785-7.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4474_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"MAB Khan","year":"2020","unstructured":"Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 diabetes -global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107\u201311. https:\/\/doi.org\/10.2991\/jegh.k.191028.001.","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"4474_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11046-021-00607-4","volume":"187","author":"LW Wei","year":"2022","unstructured":"Wei LW, Zhu PQ, Chen XQ, Yu J. Mucormycosis in Mainland China: a systematic review of case reports. Mycopathologia. 2022;187(1):1\u201314. https:\/\/doi.org\/10.1007\/s11046-021-00607-4.","journal-title":"Mycopathologia"},{"key":"4474_CR24","doi-asserted-by":"publisher","unstructured":"Bao J, Liu C, Dong Y, Xu Y, Wang Z, Sun K, Xi W, Wang K, Gong P, Gao Z. Clinical manifestations of pulmonary mucormycosis in recipients of allogeneic hematopoietic stem cell transplantation: a 21-case series report and literature review. Can Respir J. 2022; 2022:1237125. https:\/\/doi.org\/10.1155\/2022\/1237125","DOI":"10.1155\/2022\/1237125"},{"key":"4474_CR25","doi-asserted-by":"publisher","first-page":"204993612412517","DOI":"10.1177\/20499361241251744","volume":"11","author":"R Khalid","year":"2024","unstructured":"Khalid R, Khanum I, Habib K, Ali AS, Farooqi J, Iqbal N, Ejaz T, Jabeen K, Irfan M. Clinical characteristics, outcome, and factors associated with mortality of pulmonary mucormycosis: a retrospective single-center study from Pakistan. Ther Adv Infect Dis. 2024;11:20499361241251744. https:\/\/doi.org\/10.1177\/20499361241251744.","journal-title":"Ther Adv Infect Dis"},{"issue":"6","key":"4474_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3109\/13693786.2012.669502","volume":"50","author":"B Spellberg","year":"2012","unstructured":"Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EP. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012;50(6):611\u20138. https:\/\/doi.org\/10.3109\/13693786.2012.669502.","journal-title":"Med Mycol"},{"issue":"12","key":"4474_CR27","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1093\/cid\/cis298","volume":"54","author":"SA Nou\u00e9r","year":"2012","unstructured":"Nou\u00e9r SA, Nucci M, Kumar NS, Grazziutti M, Restrepo A, Anaissie E. Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis. Clin Infect Dis. 2012;54(12):e173\u201383. https:\/\/doi.org\/10.1093\/cid\/cis298.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4474_CR28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1086\/591458","volume":"198","author":"S Perkhofer","year":"2008","unstructured":"Perkhofer S, Kehrel BE, Dierich MP, Donnelly JP, Nussbaumer W, Hofmann J, von Eiff C, Lass-Fl\u00f6rl C. Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J Infect Dis. 2008;198(8):1243\u20136. https:\/\/doi.org\/10.1086\/591458.","journal-title":"J Infect Dis"},{"issue":"2","key":"4474_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/13693786.2010.510150","volume":"49","author":"S Perkhofer","year":"2011","unstructured":"Perkhofer S, Trappl K, Striessnig B, Nussbaumer W, Lass-Fl\u00f6rl C. Platelets enhance activity of antimycotic substances against non-Aspergillus fumigatus Aspergillus species in vitro. Med Mycol. 2011;49(2):157\u201366. https:\/\/doi.org\/10.3109\/13693786.2010.510150.","journal-title":"Med Mycol"},{"issue":"1","key":"4474_CR30","doi-asserted-by":"publisher","first-page":"e0009421","DOI":"10.1128\/CMR.00094-21","volume":"35","author":"F Salazar","year":"2022","unstructured":"Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev. 2022;35(1):e0009421. https:\/\/doi.org\/10.1128\/CMR.00094-21.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"4474_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s15010-018-1149-x","volume":"46","author":"J Feng","year":"2018","unstructured":"Feng J, Sun X. Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection. 2018;46(4):503\u201312. https:\/\/doi.org\/10.1007\/s15010-018-1149-x.","journal-title":"Infection"},{"issue":"Suppl 2","key":"4474_CR32","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","volume":"72","author":"BD Alexander","year":"2021","unstructured":"Alexander BD, Lamoth F, Heussel CP, Prokop CS, Desai SR, Morrissey CO, Baddley JW. Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC\/MSGERC. Clin Infect Dis. 2021;72(Suppl 2):S79\u201388. https:\/\/doi.org\/10.1093\/cid\/ciaa1855.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04474-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:26:20Z","timestamp":1793111180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04474-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4474"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04474-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"the study protocol was re-approved by the ethics committee of beijing chaoyang hospital affiliated with capital medical university (ethics no. [2026-ke-660]). all procedures involving human participants were performed in accordance with the declaration of helsinki. due to the retrospective nature of this study using de-identified medical records, the ethics committee granted a waiver of written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"318"}}